Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news



Vitamin D may be linked to multiple sclerosis activity and progression: Study

By Nathan Gray+


Vitamin D may be linked to multiple sclerosis activity and progression: Study

High levels of vitamin D may be associated with reduced disease activity and a lower risk of progression for people with multiple sclerosis (MS), according to new research.

The research, published in JAMA Neurology, examined whether serum concentrations of 25-hydroxyvitamin D (25[OH]D) is indicative of later disease activity and prognosis in people with the early stages of MS - or first event suggestive of MS (clinically isolated syndrome).

Led by Professor Alberto Ascherio from the Harvard School of Public Health, the research team assessed data from 465 participants, finding that  higher 25(OH)D levels were predictive of reduced MS activity and a slower rate of progression.

"Among patients with MS mainly treated with interferon beta-1b, low 25[OH]D levels early in the disease course are a strong risk factor for long-term MS activity and progression," wrote Ascherio and his colleagues.

Study details

The team noted that MS is a common cause of neurological disability, adding that vitamin D status has been linked to the disease process by several previous studies - some of which have suggested that people with vitamin D deficiency may be at an increased risk of the condition, while others have suggested that supplementation with the vitamin may help to easy symptoms.

The new research used data from the BENEFIT(the Betaferon/Betaseron in Newly Emerging multiple sclerosis For Initial Treatment) study to assess whether vitamin D status - as measured by serum 25[OH]D levels - were linked to later risk of disease progression in a total of 465 participants.

Patients were followed for up to five years with magnetic resonance imaging.

Ascherio and his team revealed that increases of 50-nmol/L in average blood 25[OH]D levels within the first 12 months appeared to be associated with a 57% lower risk of new active brain lesions, 57% lower risk of relapse, 25% lower yearly increase in T2 lesion volume and 0.41% lower yearly loss in brain volume from months 12 to 60 of the follow up.

Source: JAMA Neurology
Published online ahead of print, doi: 10.1001/jamaneurol.2013.5993
"Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression"
Authors: Alberto Ascherio, Kassandra L. Munger, et al

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars